Belimumab (Benlysta) Cleared in Japan for Lupus Belimumab (Benlysta) Cleared in Japan for Lupus

Belimumab is now approved in Japan for the treatment of adults with active, autoantibody-positive systemic lupus erythematosus who do not respond adequately to existing therapies.International Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news